H.C. Wainwright Reiterates Buy Rating on Telix Pharmaceuticals Ltd (TLX)

April 30, 2026 6:53 AM

H.C. Wainwright analyst Robert Burns reiterated a Buy rating and $20.00 price target on Telix Pharmaceuticals Ltd (NASDAQ: TLX).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found